Premium
Identification of a novel heparin binding domain in RHAMM and evidence that it modifies HA mediated locomotion of ras ‐transformed cells
Author(s) -
Yang Baihua,
Hall Christine L.,
Yang Bing Luo,
Savani Rashmin C.,
Turley Eva A.
Publication year - 1994
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.240560406
Subject(s) - fusion protein , receptor , motility , chondroitin sulfate , glycosaminoglycan , biochemistry , binding site , plasma protein binding , chemistry , ligand (biochemistry) , binding domain , amino acid , microbiology and biotechnology , biology , recombinant dna , gene
We have previously reported that the hyaluronan (HA) receptor RHAMM (Receptor for Mediated Motility) [Turley et al., 1991] and that HA stimulation of the motility of ras‐transformed fibroblasts is mediated via its interaction with RHAMM. Here we show that RHAMM also contains binding sites for heparin (HP) anbd that interaction of HP with these sites can regulates the locomotion of ras ‐transformed fibroblasts. At low concentrations (0.01 mg/ml), HP inhibited HA‐induced locomotion of ras ‐transformed cells in a manner independent of RHAMM. At higher, but still physioligical concentrations (0.1 mg/ml), HP alone stimulated cell locomotion and this stimulation appeared to be RHAMM‐dependent as it was blocked by anti‐RHAMM antibodies. Other related glycosaminogolycans such as chondroitin sulfate and dermatin sulfate had no effect on cell motility. In ligand blotting assays, GST‐RHAMM fusion protein was shown to bind biotin‐labelled HP and this binding was displaceable with unabelled HP. In similar lignad binding analyses conducted with truncations of RHAMM fusion protein, the binding region was found to be localizeed in the same 35 amino acid segment of RHAMM that contains the two HA binding domains. Synthetic peptides corresponding to these HA binding domains were retained on and bound effectively to an HP‐Sepharose affinity column. Fusion protein generated by linkage of these peptides to the non‐HP binding amino terminus of RHAMM conferred HP binding capacity to the genetically engineered proteins. Conversely, deletion of the HA binding domains of RHAMM resulted in fusion proteins devoid of HP binding activity. The relative affinities of RHAMM for HA and HP, as determined by competition and transblot assays as well as quantification of binding at various salt concentrations, indicated that RHAMM had lower affinity for HP than that for HA. These results demonstrate the existence of new HP binding motif that has biological relevance to locomotion.